Home Tags Clinical Trials

Clinical Trials Related Content

12-15 year olds, pfizer vaccine

Pfizer vaccine can be given to 12-15 year olds in US

On Wednesday (12 May), the CDC announced that the Pfizer vaccine could now be given to 12-15 year olds - effective immediately for 17 million adolescents.
curevac mrna vaccine, clinical trial

CureVac mRNA vaccine can be stored at normal fridge temperature

The CureVac mRNA vaccine is currently in final stages of clinical trials - but it is expected to perform like Pfizer and Moderna, with the bonus of surviving at ordinary refrigeration temperatures.
COVID vaccine 12 year olds, pfizer

Pfizer applies for COVID vaccine to be given to 12-year-olds

Pfizer could make their COVID vaccine available to 12-year-olds in Europe from June, after clinical trials in March showed 100% efficiency for those aged 12 to 15.
missing second COVID dose, pfizer

Researchers say missing second COVID dose could “prolong pandemic”

The study found that missing a second COVID dose could "prolong" the pandemic, with more than 5 million people in the US not taking their scheduled dose.
brazilian covid mutation, p.1

Brazilian COVID mutation more likely to evade immunity

The city of Manaus was hit so overwhelmingly by the Brazilian COVID mutation, it was believed that 75% of the population had COVID - what new truths are scientists learning about this powerful variant? 
astrazeneca vaccine side effects, pfizer side effects

One in four people get Pfizer and AstraZeneca vaccine side effects

New data from the UK's vaccination programme suggests that one in four people get Pfizer and AstraZeneca vaccine side effects - with most peaking in the first 24 hours, then gone in two days.
south africa johnson & johnson, africa mutation

South Africa will use Johnson & Johnson COVID vaccine

After stopping rollout in response to blood clot investigations, South Africa are now preparing to start using Johnson & Johnson COVID vaccines.
third vaccine dose, pfizer

Pfizer says people will need third vaccine dose after 12 months

Pfizer CEO Albert Bourla suggested that fully vaccinated people would need their third vaccine dose, maybe 12 months after they got their second - the EU is currently in talks to secure a further 1.8 billion doses.
moderna and novavax, mixing vaccine

New UK study will mix Moderna and Novavax COVID doses

Researchers in the UK started a clinical trial on mixing vaccines in February - today (14 April) a new study will look into mixing Moderna and Novavax doses.
johnson & johnson vaccine, astrazeneca

US stops Johnson & Johnson vaccine to investigate blood clot risk

US authorities paused the use of the Johnson & Johnson single dose vaccine as they look into six cases of blood clots that developed in women aged between 18 and 48.
COVID antibody drug, COVID-19

Clinical trial finds COVID antibody drug can prevent infection

Uninfected people lived with one infected individual as part of the study - the COVID antibody drug gave them 72% protection against catching the virus themselves.
700,000 astrazeneca, australia

Over 700,000 AstraZeneca doses sent from UK to Australia

Today (8 April) it was revealed that over 700,000 AstraZeneca doses manufactured in the UK are being sent to Australia - with a confirmed 300,000 vaccines in Sydney at the end of February.
moderna covid vaccine, pfizer

Moderna COVID vaccine rollout begins in UK

The Moderna COVID vaccine will initially be given to patients in Wales - which brings the UK up to three approved vaccines.
pfizer vaccine 100%, pfizer children

Scientists find Pfizer vaccine is 100% effective in young adolescents

The company aim to start vaccinating children by September 2021, as clinical trials reveal that Pfizer is 100% effective in those aged 12 to 15.
moderna and pfizer vaccines, united states

Moderna and Pfizer vaccines 90% effective in US real-world data

Real-world use of the Moderna and Pfizer vaccines in the United States reveals that both are working at 90% efficacy - with data pointing to one dose being capable of 80% protection.
access to treatment, NOR-SWITCH

Biosimilars: Improve access to treatment & reduce cost

Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.
vaccines for uk, astrazeneca vaccine

AstraZeneca vaccines made for UK could be kept for EU use only

EU leaders today (25 March) decided not to create an export ban for AstraZeneca vaccines made for the UK - but the feud between AstraZeneca and the bloc remains close to the surface of future discussions.
us trial astrazeneca vaccine, astrazeneca

US trial finds AstraZeneca vaccine 100% effective against COVID death

In a study of over 32,000 people, a US trial found the AstraZeneca vaccine was 100% effective against deaths caused by COVID-19 - the vaccine did not show any connection to blood clots.
artificial tear substitutes, dry eye

Polymers and polymer-based drug delivery in the treatment of dry eye disease

Professor Heather Sheardown, C20/20 Ophthalmic Materials Innovation Hub, Department of Chemical Engineering, McMaster University, explores how polymers can be used to treat dry eye disease.
cause blood clots, astrazeneca vaccine

European Medicines Agency say AstraZeneca does not cause blood clots

The safety committee of the European Medicines Agency said the investigation did not prove that AstraZeneca vaccinations cause blood clots - describing the possibility as an "extremely small likelihood".

Follow Open Access Government